Results 1 to 10 of about 4,062 (67)

Dysbiosis in the Gut-Liver Axis Is Associated With Low Bone Mass During Murine Cholestasis. [PDF]

open access: yesFASEB J
Dysbiosis in the gut‐liver axis drives a dysregulation in bile acid metabolism that increases bile acid efflux into systemic circulation and the bone marrow. Bile acid signaling in the marrow promotes osteoclastogenesis and suppresses osteoblastogenesis, which drives bone loss during cholestatic liver disease in mice. ABSTRACT The gut‐liver axis is the
Hutchison B   +7 more
europepmc   +2 more sources

Disulfiram Exhibits Potent Copper-Dependent Antimicrobial Activity Against <i>Mycoplasma genitalium</i>. [PDF]

open access: yesOpen Forum Infect Dis
Xiao L   +5 more
europepmc   +1 more source

Mechanisms of fetal growth restriction in gestational cholestasis: role of gut microbiota and placental redox. [PDF]

open access: yesFront Vet Sci
Xue Z   +9 more
europepmc   +1 more source

Engineering a heme-dependent tryptophan hydroxylase pathway in <i>E. coli</i> for enhanced melatonin production. [PDF]

open access: yesSynth Syst Biotechnol
Zhang L   +9 more
europepmc   +1 more source

Activation of aryl hydrocarbon receptor alleviates cholestatic liver injury by inhibiting inflammation. [PDF]

open access: yesCell Commun Signal
Han Q   +8 more
europepmc   +1 more source

A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders. [PDF]

open access: yesNat Med
Bolsewig K   +31 more
europepmc   +1 more source

The secretory protein, CLCF1, improves cholestatic liver disease by inhibiting hepatic bile acid synthesis and promoting bile acid excretion. [PDF]

open access: yesCommun Biol
Liu M   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy